These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study. Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792 [TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663 [TBL] [Abstract][Full Text] [Related]
8. Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation. Newman NJ; Carelli V; Taiel M; Yu-Wai-Man P J Neuroophthalmol; 2020 Dec; 40(4):547-557. PubMed ID: 32969847 [TBL] [Abstract][Full Text] [Related]
9. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON). Chan JW; Sultan W; Karanjia R; Sadun AA Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201 [TBL] [Abstract][Full Text] [Related]
10. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy. Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832 [TBL] [Abstract][Full Text] [Related]
12. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy. Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388 [TBL] [Abstract][Full Text] [Related]
13. Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation. Tonagel F; Wilhelm H; Richter P; Kelbsch C Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):1009-1013. PubMed ID: 33337510 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of treatment with idebenone in Leber's hereditary optic neuropathy in the Netherlands: A national cohort study. van Everdingen JAM; Pott JWR; Bauer NJC; Krijnen AM; Lushchyk T; Wubbels RJ Acta Ophthalmol; 2022 Sep; 100(6):700-706. PubMed ID: 35394113 [TBL] [Abstract][Full Text] [Related]
16. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345 [TBL] [Abstract][Full Text] [Related]
17. Idebenone: A Review in Leber's Hereditary Optic Neuropathy. Lyseng-Williamson KA Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925 [TBL] [Abstract][Full Text] [Related]
18. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Sadun AA; Chicani CF; Ross-Cisneros FN; Barboni P; Thoolen M; Shrader WD; Kubis K; Carelli V; Miller G Arch Neurol; 2012 Mar; 69(3):331-8. PubMed ID: 22410442 [TBL] [Abstract][Full Text] [Related]
19. Leber Hereditary Optic Neuropathy in Southwestern Ontario: A Growing List of Mutations. McDonald HM; Sadikovic B; Sheldon CA; Bursztyn LLCD Can J Neurol Sci; 2023 Sep; 50(5):738-744. PubMed ID: 35892476 [TBL] [Abstract][Full Text] [Related]